Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-06-22Clinical Trial Update: Efficacy Study on the Strategy of HSV-Tk Engineering Donor Lymphocytes to Treat Patients With High Risk Acute Leukemia [Phase 3]
Phase 3 trial evaluating HSV-Tk engineered donor lymphocytes for high-risk acute leukemia was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-06-18Clinical Trial Update: Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-002) [Phase 2]
Phase II trial update on Efprezimod Alfa (CD24Fc, MK-7110) for prevention of acute GVHD after myeloablative allogeneic HSCT; trial completed…
-
CLINICAL_TRIALS trial_result · 2021-06-14Clinical Trial Update: Intensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic Malignancies [NA]
A completed clinical trial evaluating intensity modulated total marrow irradiation (IM-TMI) for advanced hematologic malignancies, with resu…
-
CLINICAL_TRIALS trial_result · 2021-06-10Clinical Trial Update: Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia [Phase 2]
Phase 2 clinical trial update evaluating troxacitabine in patients with leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-21Clinical Trial Update: Pharmacokinetic Study of Busulfan in Allogeneic Stem Cell Transplantation in Adult Patients With Acute Leukemia [Phase 2]
Phase 2 pharmacokinetic study of busulfan in adult acute leukemia patients undergoing allogeneic stem cell transplantation.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-05-06Clinical Trial Update: Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation [Phase 3]
Phase 3 trial update on prevention of graft-versus-host disease in patients with advanced leukemia or lymphoma undergoing peripheral stem ce…
-
CLINICAL_TRIALS trial_result · 2021-02-15Clinical Trial Update: Respiratory Syncytial Virus - RSV Protocol [Phase 2]
Phase 2 RSV protocol trial completed; results posted in 2021 for a study sponsored by MD Anderson Cancer Center investigating respiratory sy…
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: Anti-CD22 CAR-T Cell Therapy Targeting B Cell Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial update for an anti-CD22 CAR-T cell therapy targeting leukemia and lymphoma.
-
CLINICAL_TRIALS trial_result · 2020-12-28Clinical Trial Update: A Study of Actonel for the Prevention of Bone Loss [Phase 3]
Phase 3 trial update for Actonel investigating bone loss prevention; the study completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-12-10Clinical Trial Update: Bone Marrow Transplant in Treating Patients With Hematologic Cancers [Phase 2]
Phase 2 clinical trial update on bone marrow transplant for hematologic cancers (completed).
-
CLINICAL_TRIALS trial_result · 2020-12-09Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 clinical trial assessing donor stem cell transplant in patients with previously treated leukemia, lymphoma, or multiple myeloma; stu…
-
CLINICAL_TRIALS trial_result · 2020-12-08Clinical Trial Update: Pharmacokinetics of Anidulafungin (Ecalta ®) Intravenous Given to Patients at High Risk for Developing Invasive Fungal Disease [Phase 2]
Phase 2 pharmacokinetics study of intravenous anidulafungin (Ecalta) in patients at high risk for invasive fungal disease has been completed…
-
CLINICAL_TRIALS trial_result · 2020-11-19Clinical Trial Update: Ikervis for DED Due to GVHD Post Allo-HSCT [Phase 4]
Clinical trial update for Ikervis in DED due to GVHD after allogeneic stem cell transplant (Phase 4) with unknown status.
-
CLINICAL_TRIALS trial_result · 2020-11-05Clinical Trial Update: Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy [Phase 2]
Phase 2 trial evaluating allogeneic stem cell transplantation for chronic myeloid leukemia patients failing TKI therapy has completed.
-
CLINICAL_TRIALS trial_result · 2020-11-02Clinical Trial Update: Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant [Phase 2]
Phase 2 trial update on non-myeloablative conditioning for unrelated donor umbilical cord blood transplant completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-10-27Clinical Trial Update: Combined Haploidentical-Cord Blood Transplantation for Adults and Children [NA]
Clinical trial update on combined haploidentical-cord blood transplantation in adults and children for leukemia and myelodysplastic syndrome…
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: An Open-Label, Phase I/II Study of Two Different Schedules of Dasatinib (Sprycel) and Decitabine (Dacogen) Used in Combination for Patients With Accelerated or Blastic Phase Chronic Myelogenous Leukemia (Protocol CA180357) [Phase 1, Phase 2]
Open-label Phase I/II study evaluating two schedules of dasatinib plus decitabine in accelerated or blastic phase chronic myeloid leukemia; …
-
CLINICAL_TRIALS trial_result · 2020-10-05Clinical Trial Update: NK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/Adolescents [Phase 2]
Phase 2 clinical trial assessing NK cells as consolidation therapy after initial treatment for acute myeloid leukemia in children and adoles…
-
CLINICAL_TRIALS trial_result · 2020-09-25Clinical Trial Update: Anti-thymocyte Globulins for Graft-versus-host Disease Prophylaxis [Phase 4]
Phase 4 trial update on anti-thymocyte globulins for graft-versus-host disease prophylaxis completed.
-
CLINICAL_TRIALS trial_result · 2020-09-22Clinical Trial Update: CD19-CART Treatment for ALL [Phase 1, Phase 2]
A phase 1/2 trial update for a CD19-CART treatment in acute leukemia has completed enrollment and status updated.
-
CLINICAL_TRIALS trial_result · 2020-09-10Clinical Trial Update: Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases [Phase 2]
Phase 2 trial evaluating myeloablative umbilical cord blood transplantation in various hematological diseases has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2020-09-09Clinical Trial Update: Ketamine-ketorolac Versus Fentanyl- Ketorolac I.M in Children During Bone Marrow Biopsy [Phase 4]
Phase 4 trial comparing ketamine-ketorolac versus fentanyl-ketorolac for analgesia in children undergoing bone marrow biopsy completed.
-
CLINICAL_TRIALS trial_result · 2020-08-26Clinical Trial Update: Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant [NA]
Clinical trial update on donor lymphocyte infusion for patients with recurrent or persistent hematologic cancer after donor stem cell transp…
-
CLINICAL_TRIALS trial_result · 2020-08-20Clinical Trial Update: Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD [Phase 2]
Phase 2 trial evaluating selective depletion of CD45RA+ T cells from allogeneic peripheral blood stem cell grafts to prevent GVHD; study ter…
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer [Phase 3]
Phase 3 trial comparing darbepoetin alfa with epoetin alfa for treating anemia in patients undergoing chemotherapy for cancer has completed.